Panbela Therapeutics, Inc. (PBLA) Tops Q1 EPS by 132c
Tweet
Share
E-mailGet Alerts PBLA Hot Sheet
Join SI Premium – FREE
Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q1 EPS of ($2.28), $1.32 better than the analyst estimate of ($3.60).
For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
